{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:59:25Z","timestamp":1791932365456,"version":"4.3.4"},"reference-count":69,"publisher":"Centers for Disease Control MMWR Office","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Recomm. Rep."],"DOI":"10.15585\/mmwr.rr7001a1","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T18:59:04Z","timestamp":1610045944000},"page":"1-12","source":"Crossref","is-referenced-by-count":58,"title":["Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020"],"prefix":"10.15585","volume":"70","author":[{"given":"Mary J.","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin M.","family":"Cossaboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy N.","family":"Whitesell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Dyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Campos-Outcalt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Person","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ervin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yon C.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre E.","family":"Rollin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Harcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Atmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth P.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Helfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger K.","family":"Damon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon E.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R1","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever.","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R2","unstructured":"CDC. [Internet]. Ebola (Ebola virus disease). Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/index-2018.html"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R3","unstructured":"Feldmann H, Sanchez A, Geisbert TW. Filoviridae: Marburg and Ebola viruses [Chapter 32]. In: Knipe D, Howley P, eds. Fields virology. Philadelphia, PA: Lippincott\/Williams & Wilkins; 2007:1409\u201348."},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R4","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am J Pathol"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/438575a","article-title":"Fruit bats as reservoirs of Ebola virus.","volume":"438","author":"Leroy","year":"2005","journal-title":"Nature"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3201\/eid0204.960407","article-title":"Experimental inoculation of plants and animals with Ebola virus.","volume":"2","author":"Swanepoel","year":"1996","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1089\/vbz.2008.0167","article-title":"Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007.","volume":"9","author":"Leroy","year":"2009","journal-title":"Vector Borne Zoonotic Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R8","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1056\/NEJMoa1404505","article-title":"Emergence of Zaire Ebola virus disease in Guinea.","volume":"371","author":"Baize","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R9","unstructured":"CDC. [Internet]. Ebola virus disease. Signs and symptoms. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https:\/\/www.cdc.gov\/vhf\/ebola\/symptoms\/index.html"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R10","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1056\/NEJMoa1409838","article-title":"Clinical care of two patients with Ebola virus disease in the United States.","volume":"371","author":"Lyon","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R11","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S0140-6736(18)33132-5","article-title":"Ebola virus disease.","volume":"393","author":"Malvy","year":"2019","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R12","doi-asserted-by":"publisher","first-page":"S810","DOI":"10.1093\/infdis\/jir299","article-title":"Basic clinical and laboratory features of filoviral hemorrhagic fever.","volume":"204","author":"Kortepeter","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7326\/M15-0530","article-title":"Characteristics and clinical management of a cluster of 3 patients with Ebola virus disease, including the first domestically acquired cases in the United States.","volume":"163","author":"Liddell","year":"2015","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1056\/NEJMoa1411249","article-title":"Clinical presentation of patients with Ebola virus disease in Conakry, Guinea.","volume":"372","author":"Bah","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R15","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1086\/520545","article-title":"Assessment of the risk of Ebola virus transmission from bodily fluids and fomites.","volume":"196","author":"Bausch","year":"2007","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R16","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1086\/514284","article-title":"Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995.","volume":"179","author":"Dowell","year":"1999","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1473-3099(15)00489-2","article-title":"Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study.","volume":"16","author":"Mattia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R18","doi-asserted-by":"publisher","first-page":"ofy239","DOI":"10.1093\/ofid\/ofy239","article-title":"Care of Ebola survivors and factors associated with clinical sequelae\u2014Monrovia, Liberia.","volume":"5","author":"de St Maurice","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R19","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1086\/514318","article-title":"Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo.","volume":"179","author":"Rowe","year":"1999","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R20","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJMoa1805435","article-title":"A longitudinal study of Ebola sequelae in Liberia.","volume":"380","author":"Sneller","year":"2019","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R21","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/S1473-3099(16)00077-3","article-title":"Sequelae of Ebola virus disease: the emergency within the emergency.","volume":"16","author":"Vetter","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R22","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1086\/514288","article-title":"Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo.","volume":"179","author":"Kibadi","year":"1999","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R23","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1056\/NEJMoa1500306","article-title":"Persistence of Ebola virus in ocular fluid during convalescence.","volume":"372","author":"Varkey","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R24","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/S1473-3099(19)30313-5","article-title":"Subsequent mortality in survivors of Ebola virus disease in Guinea: a nationwide retrospective cohort study.","volume":"19","author":"Keita","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R25","unstructured":"World Health Organization [Internet]. Clinical care of survivors of Ebola virus disease interim guidance. Geneva, Switzerland: World Health Organization; 2016. https:\/\/www.who.int\/csr\/resources\/publications\/ebola\/guidance-survivors\/en\/"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R26","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1097\/AOG.0000000000001092","article-title":"A pregnant patient with Ebola virus disease.","volume":"126","author":"Oduyebo","year":"2015","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R27","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1093\/cid\/ciw202","article-title":"Ebola virus persistence in semen of male survivors.","volume":"62","author":"Uyeki","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R28","doi-asserted-by":"publisher","first-page":"ofx155","DOI":"10.1093\/ofid\/ofx155","article-title":"Ebola virus ribonucleic acid detection in semen more than two years after resolution of acute Ebola virus infection.","volume":"4","author":"Fischer","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R29","first-page":"479","article-title":"Possible sexual transmission of Ebola virus\u2014Liberia, 2015.","volume":"64","author":"Christie","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R30","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1056\/NEJMoa1509773","article-title":"Molecular evidence of sexual transmission of Ebola virus.","volume":"373","author":"Mate","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R31","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/cid\/ciw601","article-title":"Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days.","volume":"63","author":"Diallo","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R32","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0140-6736(16)30386-5","article-title":"Late Ebola virus relapse causing meningoencephalitis: a case report.","volume":"388","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R33","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/cid\/civ1024","article-title":"Dilemmas in managing pregnant women with Ebola: 2 case reports.","volume":"62","author":"Caluwaerts","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R34","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1056\/NEJMoa1511410","article-title":"Ebola RNA persistence in semen of Ebola virus disease survivors\u2014final report.","volume":"377","author":"Deen","year":"2017","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R35","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/infdis\/jiw078","article-title":"New evidence of long-lasting persistence of Ebola virus genetic material in semen of survivors.","volume":"214","author":"Sow","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R36","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1093\/cid\/ciw202","article-title":"Ebola virus persistence in semen of male survivors.","volume":"62","author":"Uyeki","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R37","doi-asserted-by":"publisher","first-page":"e736","DOI":"10.1016\/S2214-109X(16)30175-9","article-title":"Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data.","volume":"4","author":"Soka","year":"2016","journal-title":"Lancet Glob Health"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R38","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1056\/NEJMoa1504874","article-title":"Clinical management of Ebola virus disease in the United States and Europe.","volume":"374","author":"Uyeki","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R39","doi-asserted-by":"publisher","first-page":"ofz068","DOI":"10.1093\/ofid\/ofz068","article-title":"Comprehensive clinical and laboratory follow-up of a female patient with Ebola virus disease: Sierra Leone Ebola Virus Persistence Study.","volume":"6","author":"Liu","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R40","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.1093\/infdis\/jiw254","article-title":"Ebola virus shedding and transmission: review of current evidence.","volume":"214","author":"Vetter","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R41","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3201\/eid2304.161743","article-title":"Ebola virus RNA in semen from an HIV-positive survivor of Ebola.","volume":"23","author":"Purpura","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R42","first-page":"513","article-title":"Ebola virus persistence in breast milk after no reported illness: a likely source of virus transmission from mother to child.","volume":"64","author":"Sissoko","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R43","unstructured":"CDC. [Internet]. 2014\u20132016 Ebola outbreak in West Africa. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https:\/\/www.cdc.gov\/vhf\/ebola\/history\/2014-2016-outbreak\/index.html"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R44","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0140-6736(19)30242-9","article-title":"The evolution of supportive care for Ebola virus disease.","volume":"393","author":"Lamontagne","year":"2019","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R45","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S0140-6736(17)31795-6","article-title":"Evidence-based guidelines for supportive care of patients with Ebola virus disease.","volume":"391","author":"Lamontagne","year":"2018","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R46","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A randomized, controlled trial of Ebola virus disease therapeutics.","volume":"381","author":"Mulangu","year":"2019","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.7326\/M15-0968","article-title":"Active tracing and monitoring of contacts associated with the first cluster of Ebola in the United States.","volume":"163","author":"Chung","year":"2015","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R48","first-page":"1087","article-title":"Ebola virus disease cluster in the United States\u2014Dallas County, Texas, 2014.","volume":"63","author":"Chevalier","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R49","first-page":"321","article-title":"Ebola virus disease in a humanitarian aid worker\u2014New York City, October 2014.","volume":"64","author":"Yacisin","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.7326\/M15-2944","article-title":"Addressing infection prevention and control in the first U.S. community hospital to care for patients with Ebola virus disease: context for national recommendations and future strategies.","volume":"165","author":"Cummings","year":"2016","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R51","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!).","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R52","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R53","doi-asserted-by":"publisher","first-page":"E819","DOI":"10.1503\/cmaj.170074","article-title":"Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.","volume":"189","author":"ElSherif","year":"2017","journal-title":"CMAJ"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R54","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1056\/NEJMoa1414216","article-title":"A recombinant vesicular stomatitis virus Ebola vaccine.","volume":"376","author":"Regules","year":"2017","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R55","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1093\/infdis\/jiy020","article-title":"The Sierra Leone Trial to Introduce a Vaccine against Ebola: an evaluation of rVSV\u2206G-ZEBOV-GP vaccine tolerability and safety during the West Africa Ebola outbreak.","volume":"217","author":"Samai","year":"2018","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R56","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1093\/infdis\/jix189","article-title":"Six-month safety data of recombinant vesicular stomatitis virus\u2013Zaire Ebola virus envelope glycoprotein vaccine in a phase 3 double-blind, placebo-controlled randomized study in healthy adults.","volume":"215","author":"Halperin","year":"2017","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R57","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1056\/NEJMoa1614067","article-title":"Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia.","volume":"377","author":"Kennedy","year":"2017","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R58","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","article-title":"The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1\/2 trial.","volume":"15","author":"Huttner","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R59","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","article-title":"Phase 1 trials of rVSV Ebola vaccine in Africa and Europe.","volume":"374","author":"Agnandji","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R60","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S1473-3099(17)30313-4","article-title":"Safety and immunogenicity of the rVSV\u2206G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study.","volume":"17","author":"Heppner","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R61","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/infdis\/jiz241","article-title":"Immunogenicity, lot consistency, and extended safety of rVSV\u0394G-ZEBOV-GP vaccine: a phase 3 randomized, double-blind, placebo-controlled study in healthy adults.","volume":"220","author":"Halperin","year":"2019","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R62","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3201\/eid2603.191018","article-title":"Pregnancy outcomes among women receiving rVSV\u0394-ZEBOV-GP Ebola vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola.","volume":"26","author":"Legardy-Williams","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R63","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ebiom.2017.03.045","article-title":"Dose-dependent T-cell dynamics and cytokine cascade following rVSV-ZEBOV immunization.","volume":"19","author":"Dahlke","year":"2017","journal-title":"EBioMedicine"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R64","doi-asserted-by":"publisher","first-page":"e1002402","DOI":"10.1371\/journal.pmed.1002402","article-title":"Safety and immunogenicity of rVSV\u0394G-ZEBOV-GP Ebola vaccine in adults and children in Lambar\u00e9n\u00e9, Gabon: a phase I randomised trial.","volume":"14","author":"Agnandji","year":"2017","journal-title":"PLoS Med"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R65","unstructured":"Food and Drug Administration. BLA clinical review memorandum. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2019. https:\/\/www.fda.gov\/media\/109149\/download"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R66","unstructured":"Ervebo [Package Insert]. Whitehouse Station, NJ: Merck; 2019. https:\/\/www.fda.gov\/media\/133748\/download"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R67","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/infdis\/jiy698","article-title":"PREVAIL I cluster vaccination study with rVSV\u2206G-Zebov-GP as part of a public health response in Liberia.","volume":"219","author":"Bolay","year":"2019","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R68","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S1473-3099(17)30541-8","article-title":"Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report.","volume":"17","author":"Gsell","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7001a1-202101071357-R69","unstructured":"European Medicines Agency. Ervebo assessment report. Amsterdam, The Netherlands: European Medicines Agency; 2019. https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/ervebo-epar-public-assessment-report_en.pdf"}],"container-title":["MMWR. Recommendations and Reports"],"original-title":[],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T18:59:17Z","timestamp":1610045957000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/70\/rr\/rr7001a1.htm?s_cid=rr7001a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":69,"aliases":["10.15585\/mmwr.rr.7001a1"],"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,8]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.rr7001a1","relation":{},"ISSN":["1057-5987","1545-8601"],"issn-type":[{"value":"1057-5987","type":"print"},{"value":"1545-8601","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,8]]},"published":{"date-parts":[[2021,1,8]]}}}